Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Clinical trial NCT00777231 · COMPLETED

Trial details

NCT number: NCT00777231
Sponsor: Talaris Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2005-01-01
Primary completion: 2010-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.